Oct 28, 2026 | Digital Pathology, Information Technology | Powered by Tribun Health’s CaloPix platform, the system holds FDA clearance, Health Canada licensing, CE-Marking, and Australian Register of Therapeutic Goods inclusion as a Class 1 software IVD medical device for primary diagnosis. “Digital pathology cannot…
Oct 28, 2026 | Sequencing Systems | Watchmaker Genomics has introduced Expanse Whole Genome Sequencing, a PCR-free workflow that integrates library preparation and normalization into a single process. The company announced the technology and opened an early access program ahead of a preview at…
GenomeWeb Freenome has launched its SimpleScreen Lung laboratory-developed test for lung cancer screening The test is intended for adults ages 50 to 80 with a âÂÂ¥20 pack-year smoking history who are not currently participating in guideline-recommended screening The test can be…
GenomeWeb LCMC Health, Helix Launch Louisiana Genomics Initiative
Oct 16, 2026 | Anatomic Pathology | Under the agreement, NeoGenomics selected Indica Labs’ HALO AP platform to support its digital pathology operations through a scalable, cloud-based framework. The vendor-neutral image management system provides an operating model that allows the laboratory network to integrate…
Oct 16, 2026 | Anatomic Pathology, Cancer, Digital Pathology | Aignostics has introduced HETA Clinical, a new suite of pan-cancer artificial intelligence products designed to assess whole-slide hematoxylin and eosin (H&E) images, accelerate pathology workflows, and decrease failure rates during downstream molecular testing. The…
Veracyte Nabs Medicare Reimbursement for Prosigna Breast Cancer Recurrence Risk Test GenomeWeb Veracyte Nabs Medicare Reimbursement for Prosigna Breast Cancer Recurrence Risk Test
Oct 15, 2026 | Infectious Diseases, Molecular Diagnostics | Delve Bio has launched Delve Detect Plasma, a blood-based metagenomic next-generation sequencing (mNGS) assay that enables unbiased detection of more than 68,000 bacteria, fungi, DNA and RNA viruses, and parasites with next-day results. The company introduced…
A mobile website that delivers tailored messages and the use of motivational telephone calls can each increase the uptake of genetic testing for hereditary cancers compared with usual care, a randomized trial has shown. The findings from the Michigan Genetic…
The 2026 ICoNS conference revealed fundamental disagreements over when to test, what to disclose, and how to use genetic information for newborn care By Jonathan D. Grinstein, PhD BOSTON, October 8, 2026—“How many people have gotten their whole genome sequenced?” Ten hands went…
Molecular tests from the diagnostics trade press: PCR and sequencing-based tests, CRISPR and rapid pathogen tests, and genetic diagnosis in the clinic.
An article joins this feed when it matches these terms. Each one is also a search of its own.